Position in ZTS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$9,473,231
-$8,757,705 QoQ
Shares Held
131,829
-14.5% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#240
of 1,408 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Baird Financial Group, Inc. holds $29,735,464 across 12 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (31.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
131,829 | $9,473,231 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
39,868 | $6,719,350 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
29,356 | $3,256,753 | |
| 4 | ALKS |
Alkermes plc.
|
53,267 | $2,791,190 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
65,575 | $2,273,484 | |
| 6 | VTRS |
Viatris Inc
|
130,001 | $2,064,415 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
30,708 | $1,963,776 | |
| 8 | PAHC |
Phibro Animal Health Corp
|
10,710 | $336,293 |
All Filings in ZTS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,473,231 | 131,829 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $18,230,936 | 154,225 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $21,318,814 | 169,439 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $31,560,492 | 215,695 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $71,620,660 | 459,254 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $77,088,470 | 468,196 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $75,214,514 | 461,637 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $93,135,691 | 476,690 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $80,565,418 | 464,729 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $79,037,652 | 467,098 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $84,911,534 | 430,215 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $42,643,540 | 245,106 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $41,948,288 | 243,588 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $67,622,241 | 406,286 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $64,492,403 | 440,071 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $68,142,664 | 459,523 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $79,102,057 | 460,190 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $96,233,138 | 510,277 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $127,316,795 | 521,726 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $100,263,796 | 516,451 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $98,120,030 | 526,508 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $80,574,011 | 511,646 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $83,117,741 | 502,222 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $77,855,368 | 470,795 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $63,594,370 | 464,057 | Shares | Defined | 2020-10-22 | |
| 2020-03-31 | $44,216,838 | 375,706 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||